52 North Health, founded in Cambridge, UK in 2018, focuses on innovating healthcare through advanced technology. Their mission is to enhance the quality of life for patients, particularly those living with diseases like cancer, by creating affordable and user-friendly medical devices. Their key products include Neutrocheck®, Aster™, and ACORN™, which are designed to improve health equity and outcomes. The company emphasizes ethical innovation and patient experience, engaging with users throughout the product lifecycle. With recognition in various health tech rankings and awards, 52 North Health is positioned as a leader in patient-centric healthcare solutions.

Acolyte Health is a patient engagement platform that transforms healthcare consumer activation through personalized, interactive video content. By utilizing a digital twin of healthcare professionals, the platform delivers multi-lingual video experiences that enhance patient understanding and engagement, ultimately leading to better health outcomes. The company addresses the significant issue of healthcare literacy, as over half of US consumers struggle to navigate the complex healthcare landscape. Acolyte Health's innovative approach not only improves communication efficiency but also empowers patients to take control of their healthcare journey, making it a valuable solution for providers, payers, and health organizations.

Acorai is developing a non-invasive heart failure monitoring platform that utilizes a unique combination of seismic, acoustic, visual, and electric sensors to measure intracardiac pressures. Their flagship product, the SAVE Sensor System, leverages state-of-the-art machine learning and proprietary datasets to provide accurate, actionable insights for healthcare professionals managing heart failure. With a focus on personalized treatment, Acorai aims to reduce readmission rates and improve patient stability through continuous monitoring. The company is positioned to disrupt the heart failure management market with its innovative technology and ongoing clinical validation studies, including CAPTURE-HF, which aim to confirm the efficacy of their monitoring system against traditional invasive methods.

Aevice Health is a pioneering company focused on transforming the management of chronic respiratory diseases through its innovative product, the Aevice MD, a non-invasive wearable stethoscope. This device allows for continuous monitoring of lung sounds and vital signs, enabling healthcare professionals to track patient responses to treatment plans effectively. By providing hospital-quality insights directly from home, Aevice Health enhances accessibility to respiratory care, reduces the risk of adverse events, and drives patient engagement. The company has received multiple awards for its innovation in digital health, positioning it as a leader in the respiratory care market.

Aidin is a healthcare technology company focused on improving patient outcomes through its referral management software. The platform integrates seamlessly into discharge planning workflows, allowing case managers to streamline communications and manage referrals effectively. By automating the process of generating provider listings and tracking patient experiences, Aidin helps healthcare systems reduce readmission rates and operational costs while enhancing care quality. With a strong market presence, Aidin has directed over $4.1 billion in healthcare spending to high-quality providers and boasts 100,000 monthly active users, positioning itself as a leader in the healthcare technology space.

Aiva Health provides a voice-powered healthcare assistant designed to enhance patient care and improve the efficiency of healthcare staff. Their platform utilizes conversational AI to facilitate natural language interactions with health records, automate workflows, and control smart environments, thereby reducing the workload on clinicians and enhancing patient independence. Aiva's solutions are integrated with existing enterprise systems and are deployed in leading hospitals and senior living communities, showcasing significant traction and a strong market position in the healthcare technology sector.

Alva Health is a Yale technology startup that is developing a wearable neuromonitoring platform with the first indication in real-time stroke detection, for payers that provide healthcare coverage to populations with high incidence of cardiovascular disease and stroke. Alva Health recently raised $1.5MM in non-dilutive funding from the National Science Foundation and National Institutes of Health SBIR programs to develop their pre-production device. Their founders have a track record of inventing and validating neurotechnologies through the FDA, as well as B2B sales in the medical device industry, and they were named one of the Top 50 MedTech startups worldwide in 2021 by MedTech Innovator.

AMPAworks is a technology company that empowers supply chain leaders to manage inventory remotely through cutting-edge AI cameras and software applications. Their solutions automate inventory tracking, providing 24/7 visibility and reducing costs for organizations, particularly in healthcare and military sectors. Trusted by over 28 organizations, AMPAworks has demonstrated significant traction with reported cost reductions of $15 million and a 72% decrease in stock-outs, positioning itself as a leader in inventory management solutions.

Applied VR is a pioneering company in immersive therapeutics, focusing on transforming chronic pain and mental health treatment through virtual reality. Their flagship product, Relie VRx, empowers patients to manage pain through evidence-based techniques, offering a drug-free alternative to traditional treatments. With a commitment to scientific rigor and patient-centered care, Applied VR aims to establish itself as the leading digital pain management platform, addressing the needs of millions suffering from chronic pain. The company has garnered attention for its innovative approach and is positioned to make a significant impact in the healthcare industry.

Osara Health is transforming cancer care by empowering individuals and organizations affected by cancer through a combination of clinical expertise, empathy, and technology. Their key offerings include personalized health coaching, evidence-based educational resources, and a dedicated app that supports users throughout their cancer journey. By focusing on both patients and caregivers, Osara Health differentiates itself with a holistic approach that emphasizes mental and physical well-being, resulting in improved health outcomes. With a strong traction of millions of people accessing their programs, Osara Health is positioned as a leader in the cancer care market, aiming to change the narrative around cancer and support individuals in thriving despite their diagnosis.

CARI Health is pioneering remote medication monitoring through innovative wearable sensors that provide real-time medication level data to clinicians. This technology allows for personalized dosage adjustments and timely alerts to patients and healthcare providers, significantly enhancing patient care in the context of opioid treatment. Founded in 2015 and incorporated in 2021, CARI Health is positioned to make a substantial impact on the opioid crisis by improving medication adherence and monitoring. The company has received notable funding, including a recent NIH grant, indicating strong traction and market interest in their solutions.

The Cedars-Sinai Accelerator is a three-month program based in Los Angeles, California, designed to transform healthcare quality and efficiency by supporting health-tech startups. It provides participating companies with $100,000 in funding, mentorship from over 300 leading clinicians and executives, and access to a vast network of healthcare entrepreneurs and investors. Since its inception in 2016, the accelerator has successfully helped numerous companies innovate and improve healthcare delivery and patient care, positioning itself as a key player in the health-tech ecosystem.